Arctic Bioscience AS (ABS.OL)

NOK 1.9

(-5.0%)

Long Term Debt Summary of Arctic Bioscience AS

  • Arctic Bioscience AS's latest annual long term debt in 2023 was 2.04 Million NOK , down 0.0% from previous year.
  • Arctic Bioscience AS's latest quarterly long term debt in 2023 FY was 2.04 Million NOK , down 0.0% from previous quarter.
  • Arctic Bioscience AS reported annual long term debt of - NOK in 2022, down 0.0% from previous year.
  • Arctic Bioscience AS reported annual long term debt of - NOK in 2021, down -100.0% from previous year.
  • Arctic Bioscience AS reported quarterly long term debt of - NOK for 2023 Q1, down 0.0% from previous quarter.
  • Arctic Bioscience AS reported quarterly long term debt of 2.04 Million NOK for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Arctic Bioscience AS (2023 - 2018)

Historical Annual Long Term Debt of Arctic Bioscience AS (2023 - 2018)

Year Long Term Debt Long Term Debt Growth
2023 2.04 Million NOK 0.0%
2022 - NOK 0.0%
2021 - NOK -100.0%
2020 6.57 Million NOK -8.14%
2019 7.15 Million NOK -13.13%
2018 8.24 Million NOK 0.0%

Peer Long Term Debt Comparison of Arctic Bioscience AS

Name Long Term Debt Long Term Debt Difference
Aqua Bio Technology ASA - NOK -Infinity%
ArcticZymes Technologies ASA 8.41 Million NOK 75.651%
BerGenBio ASA - NOK -Infinity%
Hofseth BioCare ASA 97.1 Million NOK 97.89%
PCI Biotech Holding ASA - NOK -Infinity%
Thor Medical ASA - NOK -Infinity%
Ultimovacs ASA 1.88 Million NOK -8.628%